SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Manuel Rodriguez, Clara Rodriguez-Sabate, Ingrid Morales, Alberto Sanchez, Magdalena Sabate, Parkinson's disease as a result of aging, Aging Cell, 2015, 14, 2
  2. 2
    T.I. Omotayo, G.S. Akinyemi, P.A. Omololu, B.O. Ajayi, A.A. Akindahunsi, J.B.T. Rocha, I.J. Kade, Possible involvement of membrane lipids peroxidation and oxidation of catalytically essential thiols of the cerebral transmembrane sodium pump as component mechanisms of iron-mediated oxidative stress-linked dysfunction of the pump's activity, Redox Biology, 2015, 4, 234

    CrossRef

  3. 3
    F. J. A. Meijer, A. van Rumund, B. A. C. M. Fasen, I. Titulaer, M. Aerts, R. Esselink, B. R. Bloem, M. M. Verbeek, B. Goraj, Susceptibility-Weighted Imaging Improves the Diagnostic Accuracy of 3T Brain MRI in the Work-Up of Parkinsonism, American Journal of Neuroradiology, 2015, 36, 3, 454

    CrossRef

  4. 4
    Pedro Ayuso, Carmen Martínez, Pau Pastor, Oswaldo Lorenzo-Betancor, Antonio Luengo, Félix J. Jiménez-Jiménez, Hortensia Alonso-Navarro, José A. G. Agúndez, Elena García-Martín, An association study between Heme oxygenase-1 genetic variants and Parkinson's disease, Frontiers in Cellular Neuroscience, 2014, 8,

    CrossRef

  5. 5
    Tae-Hyoung Kim, Jae-Hyeok Lee, Application of Iron Related Magnetic Resonance Imaging in the Neurological Disorders, Korean Journal of Clinical Neurophysiology, 2014, 16, 1, 1

    CrossRef

  6. 6
    Hao-Yun Zhang, Ning Song, Hong Jiang, Ming-Xia Bi, Jun-Xia Xie, Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor inhibit ferrous iron influx via divalent metal transporter 1 and iron regulatory protein 1 regulation in ventral mesencephalic neurons, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014, 1843, 12, 2967

    CrossRef

  7. 7
    Jae-Hyeok Lee, Yong-Hee Han, Jae-Wook Cho, Jin-Seong Lee, Sang-Jae Lee, Dae-Jin Kim, Tae-Hyoung Kim, Bok-Man Kang, Tae-Hyung Kim, Chi-Woong Mun, Evaluation of brain iron content in idiopathic REM sleep behavior disorder using quantitative magnetic resonance imaging, Parkinsonism & Related Disorders, 2014, 20, 7, 776

    CrossRef

  8. 8
    Xinglong Yang, Yanming Xu, Mutations in theATP13A2Gene and Parkinsonism: A Preliminary Review, BioMed Research International, 2014, 2014, 1

    CrossRef

  9. 9
    Wei Zhang, Zhao-fen Yan, Jun-hua Gao, Li Sun, Xi-yan Huang, Zhuo Liu, Shu-yang Yu, Chen-Jie Cao, Li-jun Zuo, Ze-Jie Chen, Yang Hu, Fang Wang, Jau-shyong Hong, Xiao-min Wang, Role and Mechanism of Microglial Activation in Iron-Induced Selective and Progressive Dopaminergic Neurodegeneration, Molecular Neurobiology, 2014, 49, 3, 1153

    CrossRef

  10. 10
    Manuel Rodriguez, Ingrid Morales, Clara Rodriguez-Sabate, Alberto Sanchez, Rafael Castro, Jose Miguel Brito, Magdalena Sabate, The degeneration and replacement of dopamine cells in Parkinson’s disease: the role of aging, Frontiers in Neuroanatomy, 2014, 8,

    CrossRef

  11. 11
    Petr Dusek, Per M. Roos, Tomasz Litwin, Susanne A. Schneider, Trond Peder Flaten, Jan Aaseth, The neurotoxicity of iron, copper and manganese in Parkinson's and Wilson's diseases, Journal of Trace Elements in Medicine and Biology, 2014,

    CrossRef

  12. 12
    Stefan Williams, Maruthi Ravi Vinjam, Azzam Ismail, Ahamad Hassan, A parkinsonian movement disorder with brain iron deposition and a haemochromatosis mutation, Journal of Neurology, 2013, 260, 8, 2170

    CrossRef

  13. 13
    Xixun Du, Huamin Xu, Hong Jiang, Junxia Xie, Akt/Nrf2 Activated Upregulation of Heme Oxygenase-1 Involves in the Role of Rg1 Against Ferrous Iron-Induced Neurotoxicity in SK-N-SH Cells, Neurotoxicity Research, 2013, 24, 1, 71

    CrossRef

  14. 14
    Thomas Müller, Detoxification and antioxidative therapy for levodopa-induced neurodegeneration in Parkinson’s disease, Expert Review of Neurotherapeutics, 2013, 13, 6, 707

    CrossRef

  15. 15
    Dominic J. Hare, Paul A. Adlard, Philip A. Doble, David I. Finkelstein, Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity, Metallomics, 2013, 5, 2, 91

    CrossRef

  16. 16
    Shingo Kakeda, Yukunori Korogi, Tetsuya Yoneda, Keita Watanabe, Junji Moriya, Yu Murakami, Toru Sato, Yasuhiro Hiai, Norihiro Ohnari, Satoru Ide, Kazumasa Okada, Takenori Uozumi, Sadatoshi Tsuji, Toshinori Hirai, Yasuyuki Yamashita, Parkinson’s disease: diagnostic potential of high-resolution phase difference enhanced MR imaging at 3 T, European Radiology, 2013, 23, 4, 1102

    CrossRef

  17. 17
    B.-R. Choi, S. Bang, Y. Chen, J.H. Cheah, S.F. Kim, PKA modulates iron trafficking in the striatum via small GTPase, Rhes, Neuroscience, 2013, 253, 214

    CrossRef

  18. 18
    Ci Wang, Guoguang Fan, Ke Xu, Shanshan Wang, Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): A preliminary cross-sectional study of 20 Parkinson’s disease patients, Magnetic Resonance Imaging, 2013, 31, 7, 1068

    CrossRef

  19. 19
    Jae-Hyeok Lee, Yong-Hee Han, Bok-Man Kang, Chi-Woong Mun, Sang-Jae Lee, Seung-Kug Baik, Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy, Journal of Neurology, 2013, 260, 8, 2094

    CrossRef

  20. 20
    Qing He, Ning Song, Fengjv Jia, Huamin Xu, Xiaojun Yu, Junxia Xie, Hong Jiang, Role of α-synuclein aggregation and the nuclear factor E2-related factor 2/heme oxygenase-1 pathway in iron-induced neurotoxicity, The International Journal of Biochemistry & Cell Biology, 2013, 45, 6, 1019

    CrossRef

  21. 21
    Yong-Hee Han, Jae-Hyeok Lee, Bok-Man Kang, Chi-Woong Mun, Seung-Kug Baik, Yong-il Shin, Kyu-Hyun Park, Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy, Journal of the Neurological Sciences, 2013, 325, 1-2, 29

    CrossRef

  22. 22
    Roberta Asci, Fara Vallefuoco, Immacolata Andolfo, Mariasole Bruno, Luigia De Falco, Achille Iolascon, Trasferrin receptor 2 gene regulation by microRNA 221 in SH-SY5Y cells treated with MPP+ as Parkinson's disease cellular model, Neuroscience Research, 2013, 77, 3, 121

    CrossRef

  23. 23
    Tanja Dučić, Elisabeth Barski, Murielle Salome, Jan C. Koch, Mathias Bähr, Paul Lingor, X-ray fluorescence analysis of iron and manganese distribution in primary dopaminergic neurons, Journal of Neurochemistry, 2013, 124, 2
  24. 24
    Y. Wang, S. R. Butros, X. Shuai, Y. Dai, C. Chen, M. Liu, E. M. Haacke, J. Hu, H. Xu, Different Iron-Deposition Patterns of Multiple System Atrophy with Predominant Parkinsonism and Idiopathetic Parkinson Diseases Demonstrated by Phase-Corrected Susceptibility-Weighted Imaging, American Journal of Neuroradiology, 2012, 33, 2, 266

    CrossRef

  25. 25
    Petr Dusek, Joseph Jankovic, Weidong Le, Iron dysregulation in movement disorders, Neurobiology of Disease, 2012, 46, 1, 1

    CrossRef

  26. 26
    Heba M. Saadeldien, Aml A. Mohamed, Mahmoud Rezk Abdelwahed Hussein, Iron-induced Damage in Corpus Striatal Cells of Neonatal Rats: Attenuation by Folic Acid, Ultrastructural Pathology, 2012, 36, 2, 89

    CrossRef

  27. 27
    Hyman M. Schipper, Neurodegeneration with brain iron accumulation — Clinical syndromes and neuroimaging, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012, 1822, 3, 350

    CrossRef

  28. 28
    ZeGang Ma, Yu Zhou, JunXia Xie, Nifedipine Prevents Iron Accumulation and Reverses Iron-Overload-Induced Dopamine Neuron Degeneration in the Substantia Nigra of Rats, Neurotoxicity Research, 2012, 22, 4, 274

    CrossRef

  29. 29
    L. Jin, J. Wang, H. Jin, G. Fei, Y. Zhang, W. Chen, L. Zhao, N. Zhao, X. Sun, M. Zeng, C. Zhong, Nigral iron deposition occurs across motor phenotypes of Parkinson’s disease, European Journal of Neurology, 2012, 19, 7
  30. 30
    Donald J. Lehmann, Maaike Schuur, Donald R. Warden, Naomi Hammond, Olivia Belbin, Heike Kölsch, Michael G. Lehmann, Gordon K. Wilcock, Kristelle Brown, Patrick G. Kehoe, Chris M. Morris, Rachel Barker, Eliecer Coto, Victoria Alvarez, Panos Deloukas, Ignacio Mateo, Rhian Gwilliam, Onofre Combarros, Alejandro Arias-Vásquez, Yurii S. Aulchenko, M. Arfan Ikram, Monique M. Breteler, Cornelia M. van Duijn, Abderrahim Oulhaj, Reinhard Heun, Mario Cortina-Borja, Kevin Morgan, Kathryn Robson, A. David Smith, Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project, Neurobiology of Aging, 2012, 33, 1, 202.e1

    CrossRef

  31. 31
    Daniela Berg, Bettina Faust, Alexandra Gaenslen, Parkinson's Disease, Second Edition, 2012,

    CrossRef

  32. 32
    Qing He, Ning Song, Huamin Xu, Rong Wang, Junxia Xie, Hong Jiang, Alpha-synuclein aggregation is involved in the toxicity induced by ferric iron to SK-N-SH neuroblastoma cells, Journal of Neural Transmission, 2011, 118, 3, 397

    CrossRef

  33. 33
    L. Jin, J. Wang, L. Zhao, H. Jin, G. Fei, Y. Zhang, M. Zeng, C. Zhong, Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease, Brain, 2011, 134, 1, 50

    CrossRef

  34. 34
    Lin Li, Christian Holscher, Bing-Bing Chen, Zhi-Feng Zhang, Yue-Ze Liu, Hepcidin Treatment Modulates the Expression of Divalent Metal Transporter-1, Ceruloplasmin, and Ferroportin-1 in the Rat Cerebral Cortex and Hippocampus, Biological Trace Element Research, 2011, 143, 3, 1581

    CrossRef

  35. 35
    Hassan Imran Afridi, Tasneem Gul Kazi, Atif G. Kazi, Faheem Shah, Sham Kumar Wadhwa, Nida Fatima Kolachi, Abdul Qadir Shah, Jameel Ahmed Baig, Naveed Kazi, Levels of Arsenic, Cadmium, Lead, Manganese and Zinc in Biological Samples of Paralysed Steel Mill Workers with Related to Controls, Biological Trace Element Research, 2011, 144, 1-3, 164

    CrossRef

  36. 36
    Wenjing Li, Hong Jiang, Ning Song, Junxia Xie, Oxidative Stress Partially Contributes to Iron-Induced Alpha-Synuclein Aggregation in SK-N-SH Cells, Neurotoxicity Research, 2011, 19, 3, 435

    CrossRef

  37. 37
    J. R. Cannon, J. T. Greenamyre, The Role of Environmental Exposures in Neurodegeneration and Neurodegenerative Diseases, Toxicological Sciences, 2011, 124, 2, 225

    CrossRef

  38. 38
    Massimiliano Di Filippo, Piero Floridi, Vera Rossi, Emanuele Mattucci, Aroldo Rossi, Paolo Calabresi, Nicola Tambasco, A young patient with type C multiple system atrophy and hereditary hemochromatosis, Journal of Neurology, 2010, 257, 2, 294

    CrossRef

  39. 39
    Nidhi Saini, Sandra Oelhafen, Haiqing Hua, Oleg Georgiev, Walter Schaffner, Hansruedi Büeler, Extended lifespan of Drosophila parkin mutants through sequestration of redox-active metals and enhancement of anti-oxidative pathways, Neurobiology of Disease, 2010, 40, 1, 82

    CrossRef

  40. 40
    Ning Song, Jun Wang, Hong Jiang, Junxia Xie, Ferroportin1 and hephaestin overexpression attenuate iron-induced oxidative stress in MES23.5 dopaminergic cells, Journal of Cellular Biochemistry, 2010, 110, 5
  41. 41
    Wen Zhu, Xuping Li, Wenjie Xie, Feifei Luo, Deepinder Kaur, Julie K. Andersen, Joseph Jankovic, Weidong Le, Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration, Neurobiology of Disease, 2010, 37, 2, 307

    CrossRef

  42. 42
    Chiaki Isobe, Takashi Abe, Yasuo Terayama, L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson’s disease, Journal of Clinical Neuroscience, 2010, 17, 6, 717

    CrossRef

  43. 43
    Eric Mills, Xian-ping Dong, Fudi Wang, Haoxing Xu, Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders, Future Medicinal Chemistry, 2010, 2, 1, 51

    CrossRef

  44. 44
    Simon Baudrexel, Lucas Nürnberger, Udo Rüb, Carola Seifried, Johannes C. Klein, Thomas Deller, Helmuth Steinmetz, Ralf Deichmann, Rüdiger Hilker, Quantitative mapping of T1 and T2* discloses nigral and brainstem pathology in early Parkinson's disease, NeuroImage, 2010, 51, 2, 512

    CrossRef

  45. 45
    Douglas B. Kell, Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examples, Archives of Toxicology, 2010, 84, 11, 825

    CrossRef

  46. 46
    Hong Jiang, Ning Song, Huamin Xu, Shuzhen Zhang, Jun Wang, Junxia Xie, Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent, Cell Research, 2010, 20, 3, 345

    CrossRef

  47. 47
    Thomas Müller, Basic Aspects of Catechol-O-Methyltransferase and the Clinical Applications of its Inhibitors, 2010,

    CrossRef

  48. 48
    Erin E. Battin, Julia L. Brumaghim, Antioxidant Activity of Sulfur and Selenium: A Review of Reactive Oxygen Species Scavenging, Glutathione Peroxidase, and Metal-Binding Antioxidant Mechanisms, Cell Biochemistry and Biophysics, 2009, 55, 1, 1

    CrossRef

  49. 49
    Oraporn Sitburana, William G. Ondo, Brain magnetic resonance imaging (MRI) in parkinsonian disorders, Parkinsonism & Related Disorders, 2009, 15, 3, 165

    CrossRef

  50. 50
    Noemi Morello, Elisabetta Tonoli, Federica Logrand, Veronica Fiorito, Sharmila Fagoonee, Emilia Turco, Lorenzo Silengo, Alessandro Vercelli, Fiorella Altruda, Emanuela Tolosano, Haemopexin affects iron distribution and ferritin expression in mouse brain, Journal of Cellular and Molecular Medicine, 2009, 13, 10
  51. You have free access to this content51
    Sarah Jesse, Petra Steinacker, Stefan Lehnert, Frank Gillardon, Bastian Hengerer, Markus Otto, Neurochemical Approaches in the Laboratory Diagnosis of Parkinson and Parkinson Dementia Syndromes: A Review, CNS Neuroscience & Therapeutics, 2009, 15, 2
  52. 52
    Stefan Schildknecht, Dominik Pöltl, Daniel M. Nagel, Florian Matt, Diana Scholz, Julie Lotharius, Nathalie Schmieg, Alberto Salvo-Vargas, Marcel Leist, Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells, Toxicology and Applied Pharmacology, 2009, 241, 1, 23

    CrossRef

  53. 53
    M. Biagioli, M. Pinto, D. Cesselli, M. Zaninello, D. Lazarevic, P. Roncaglia, R. Simone, C. Vlachouli, C. Plessy, N. Bertin, A. Beltrami, K. Kobayashi, V. Gallo, C. Santoro, I. Ferrer, S. Rivella, C. A. Beltrami, P. Carninci, E. Raviola, S. Gustincich, Unexpected expression of  - and  -globin in mesencephalic dopaminergic neurons and glial cells, Proceedings of the National Academy of Sciences, 2009, 106, 36, 15454

    CrossRef

  54. 54
    Shuzhen Zhang, Jun Wang, Ning Song, Junxia Xie, Hong Jiang, Up-regulation of divalent metal transporter 1 is involved in 1-methyl-4-phenylpyridinium (MPP+)-induced apoptosis in MES23.5 cells, Neurobiology of Aging, 2009, 30, 9, 1466

    CrossRef

  55. 55
    Jolanta Galazka-Friedman, Iron as a risk factor in neurological diseases, Hyperfine Interactions, 2008, 182, 1-3, 31

    CrossRef

  56. 56
    K. J. Bharucha, J. K. Friedman, A. S. Vincent, E. D. Ross, Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson’s disease, Journal of Neurology, 2008, 255, 12, 1957

    CrossRef

  57. 57
    Erin E. Battin, Julia L. Brumaghim, Metal specificity in DNA damage prevention by sulfur antioxidants, Journal of Inorganic Biochemistry, 2008, 102, 12, 2036

    CrossRef

  58. 58
    Hua-Min Xu, Hong Jiang, Jun Wang, Bing Luo, Jun-Xia Xie, Over-expressed human divalent metal transporter 1 is involved in iron accumulation in MES23.5 cells, Neurochemistry International, 2008, 52, 6, 1044

    CrossRef

  59. 59
    Edward M. Mager, Henri Wintz, Chris D. Vulpe, Kevin V. Brix, Martin Grosell, Toxicogenomics of water chemistry influence on chronic lead exposure to the fathead minnow (Pimephales promelas), Aquatic Toxicology, 2008, 87, 3, 200

    CrossRef

  60. 60
    Barbara Foglieni, Francesca Ferrari, Stefano Goldwurm, Paolo Santambrogio, Emanuela Castiglioni, Maria Sessa, Maria Antonietta Volontè, Stefania Lalli, Carlo Galli, Xin-Sheng Wang, James Connor, Francesca Sironi, Margherita Canesi, Giorgio Biasiotto, Gianni Pezzoli, Sonia Levi, Maurizio Ferrari, Paolo Arosio, Laura Cremonesi, Analysis of ferritin genes in Parkinson disease, Clinical Chemical Laboratory Medicine, 2007, 45, 11

    CrossRef

  61. 61
    Ya Ke, Zhong Ming Qian, Brain iron metabolism: Neurobiology and neurochemistry, Progress in Neurobiology, 2007, 83, 3, 149

    CrossRef

  62. 62
    Ning Song, Hong Jiang, Jun Wang, Jun-Xia Xie, Divalent metal transporter 1 up-regulation is involved in the 6-hydroxydopamine-induced ferrous iron influx, Journal of Neuroscience Research, 2007, 85, 14
  63. 63
    James Stankiewicz, S. Scott Panter, Mohit Neema, Ashish Arora, Courtney E. Batt, Rohit Bakshi, Iron in chronic brain disorders: Imaging and neurotherapeutic implications, Neurotherapeutics, 2007, 4, 3, 371

    CrossRef

  64. 64
    Judit Várkonyi, Miklós Molnár, Margit Kovács, Zoltán Prohászka, Iron Overload in Gaucher Cells and Bone Marrow that Is Not Associated with Hemochromatosis Gene Mutations C282Y and H63D in a Patient Having Coexistent Gaucher and Parkinson’s Disease, Hungarian Medical Journal, 2007, 1, 3, 371

    CrossRef

  65. 65
    Frédéric Sedel, Olivier Lyon-Caen, Jean-Marie Saudubray, Therapy Insight: inborn errors of metabolism in adult neurology—a clinical approach focused on treatable diseases, Nature Clinical Practice Neurology, 2007, 3, 5, 279

    CrossRef

  66. 66
    John E. Duda, Kurt A. Jellinger, Neurodegeneration with Brain Iron Accumulation,